Drug Utilization Review Board Seeks 2 Physician Members

January 8, 2026

The Minnesota Department of Human Services (DHS) has two open physician seats on its Minnesota Health Care Program’s Drug Utilization Review (DUR) Board. 

The board was formed to: 

  • monitor the prescription of covered outpatient drugs for recipients of Medicaid, 

  • oversee prospective and retrospective interventions to target common drug therapy problems,  

  • monitor the landscape of opioid and psychotropic medication prescribing, and  

  • assess financial impact of interventions in the fee-for-service (FFS) Minnesota Medicaid population. 

Qualified applicants must be actively practicing MDs or DOs in Minnesota with knowledge of appropriate prescribing, dispensing, and monitoring of covered outpatient drugs.  

The DUR Board meets four times annually for up to two hours. There are options for in-person or virtual attendance, and Board members receive a $100 stipend per meeting attended. Term length is three years. 

Applications are accepted through the Office of the Minnesota Secretary of State Boards and Commissions website, or via e-mail request to Erin Neumann, DUR coordinator. Applications received before February 6 will be considered for appointment at the March 2026 DUR Board meeting. 

For more information, reach out to Erin Neumann

Latest News

Physician/Olympian to Give Inspirational Address at Empowering Physicians Event

August 20, 2026

A physician and Olympian will give an inspirational address as part of this year's Empowering Physicians event on Friday, September 25, at the Minneapolis Institute of Art.

Minnesota Vaccination Rates Trending in Wrong Direction

August 20, 2026

Minnesota received some disturbing news this week from the Centers for Disease Control and Prevention (CDC), as data shows that for the 2025-2026 school year, vaccination rates decreased and non-medical exemptions increased.  

Appellate Court Sides with Texas Medical Association in No Suprises Act Lawsuit

August 20, 2026

On August 11, a federal appellate court sided with the Texas Medical Association (TMA) argument that the way the No Surprises Act’s qualifying payment amount (QPA) is calculated has historically favored payers in arbitration.